Home
email to Cefak KG
German

Cefamadar®

Tablets, drops

Cefamadar

basic information

This product information corresponds to the patient leaflet, prescribed by law in Germany, in all essential parts.
 
Field of application:
according to the homeopathic drug picture: among that is: adiposity. Note: before taking the medicine, please make sure that adiposity is not due to an illness.
 
Composition:
Active ingredient:
Tablets: 1 tablet contains: Madar(GHP 34) trit. D4 250 mg
(GHP, regulation 4a)
Drops: 10 ml contain: Madar (GHP 34) dil. D4 10 ml
(GHP, regulation 4a)
 
Excipients:
Tablets: lactose, magnesium stearate.
 
Contra-indications:
Tablets: must not be used by infants.
Drops: there is no experience concerning the use of this remedy by children. Therefore and due to the alcohol content, Cefamadar® drops should not be used by children under 12 years. For children under 12 years, Cefamadar® is available in the form of tablets. Must not be used by alcoholics. Persons suffering from liver diseases should consult their physician.
 
Warning:
Cefamadar® drops contain 72 vol.-% alcohol.
 
Dosage:
Tablets: unless otherwise prescribed, 1 tablet is taken once to three times a day. Toddlers up to 6 years take not more than half of the adult dose, children from 6 - 12 years take not more than 2/3 of the adult dose.
Drops: unless otherwise prescribed, 5 - 10 drops are taken once to three times a day.
 
Kind and duration of application:
Tablets: Cefamadar® tablets can be chewed or swallowed with some liquid.
Drops: Cefamadar® drops can be taken undiluted or diluted with some liquid, e.g. water.
Even homeopathic remedies should not be taken over a longer period of time without consulting a physician.
 
Undesirable effects:
none known. Note: existing complaints may temporarily appear to become worse when homeopathic agents are taken (homeopathic aggravation).
 
For any questions about risks and side effects please read the leaflet or ask your doctor or pharmacist.

Madar
products A-Z

© Cefak KG, D-87437 Kempten/Germany Imprint | Privacy Policy | Terms of use